Skip to main content
Equibles

BANK OF AMERICA CORP /DE/

Bank

Position in GNLX — GENELUX Corp

CIK 70858 CHARLOTTE, NC
Back to GNLX Full portfolio

Position in GNLX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$989,697
+$205,944 QoQ
Shares Held
328,803
+1.5% QoQ
Ownership
0.727%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#7
of 72 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GNLX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BANK OF AMERICA CORP /DE/ holds $10,144,297,346 across 338 Biotechnology names. GNLX ranks #217 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,039,178 $1,509,650,884
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,291,053 $805,023,185
3 CYTK
Cytokinetics Inc
 4,635,709 $394,916,048
4 ARGX
Argenx SE
 400,234 $371,325,094
5 ALNY
Alnylam Pharmaceuticals, Inc.
 994,476 $299,367,107
6 JAZZ
Jazz Pharmaceuticals plc
 1,136,091 $273,763,844
7 TVTX
Travere Therapeutics, Inc.
 4,568,341 $259,527,450
8 RPRX
Royalty Pharma plc
 4,149,422 $232,658,090

All Filings in GNLX

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $989,697 328,803
2026-03-31 $783,753 323,865
2025-12-31 $1,465,051 336,021
2025-09-30 $1,358,674 323,494
2025-06-30 $1,172,945 408,692
2025-03-31 $1,103,303 408,631
2024-12-31 $512,369 217,106
2024-09-30 $513,770 216,781
2024-06-30 $556,586 285,429
2024-03-31 $307,385 47,805
2023-12-31 $330,452 23,587
2023-09-30 $570,885 23,311
2023-06-30 $104,704 3,200